Quest PharmaTech Inc (V:QPT) — Stock Price
Quest PharmaTech Inc (V:QPT) is currently trading at CA$0.03 CAD, up 20.00% today. Over the past 52 weeks, shares have ranged between CA$0.02 and CA$0.05. This page tracks Quest PharmaTech Inc's live share price on the V exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see how efficiently does Quest PharmaTech Inc generate cash.
Quest PharmaTech Inc (QPT) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Quest PharmaTech Inc's daily closing share price and trading volume on the V exchange over the past year, giving a clear view of recent price momentum and liquidity.
Quest PharmaTech Inc Income Statement — Revenue, Profit & Earnings by Year
Quest PharmaTech Inc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CA$0.00 | CA$0.00 | CA$0.00 | CA$0.00 | CA$0.00 |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Research & Development | CA$329.18K | CA$542.86K | CA$336.23K | CA$170.24K | CA$212.50K |
| SG&A | CA$488.10K | CA$772.96K | CA$497.99K | CA$620.34K | CA$857.84K |
| Total Operating Expenses | CA$817.28K | CA$1.32 Million | CA$834.22K | CA$790.57K | CA$1.07 Million |
| Operating Income | CA$-817.28K | CA$-1.32 Million | CA$-834.22K | CA$-790.57K | CA$-1.07 Million |
| EBITDA | — | — | CA$-7.30 Million | CA$-84.99 Million | CA$190.11 Million |
| EBIT | — | — | CA$-834.22K | CA$-790.57K | CA$-1.07 Million |
| Interest Expense | CA$22.64K | CA$20.68K | CA$21.00K | CA$13.06K | CA$7.77K |
| Income Before Tax | CA$-1.80 Million | CA$-3.02 Million | CA$-7.33 Million | CA$-85.04 Million | CA$190.06 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | CA$-1.80 Million | CA$-3.02 Million | CA$-7.33 Million | CA$-85.04 Million | CA$190.06 Million |
Quest PharmaTech Inc Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Quest PharmaTech Inc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CA$22.56 Million | CA$24.48 Million | CA$84.36 Million | CA$91.03 Million | CA$175.61 Million |
| Total Current Assets | CA$225.28K | CA$835.53K | CA$621.50K | CA$288.15K | CA$281.45K |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | CA$0.00 |
| Net Receivables | — | — | CA$221.31K | CA$320.00 | CA$32.73K |
| Inventory | — | — | — | — | — |
| Property, Plant & Equipment | — | — | CA$2.97K | CA$16.46K | CA$55.02K |
| Goodwill | — | — | — | — | — |
| Total Liabilities | CA$1.17 Million | CA$1.32 Million | CA$1.11 Million | CA$622.60K | CA$389.44K |
| Total Current Liabilities | CA$1.17 Million | CA$1.32 Million | CA$1.11 Million | CA$622.60K | CA$375.44K |
| Long-term Debt | — | — | — | — | — |
| Net Debt | CA$794.91K | CA$283.04K | CA$625.34K | CA$235.66K | CA$50.89K |
| Total Stockholder Equity | CA$21.40 Million | CA$23.15 Million | CA$83.25 Million | CA$90.41 Million | CA$175.22 Million |
| Retained Earnings | CA$-20.88 Million | CA$-19.08 Million | CA$41.49 Million | CA$48.78 Million | CA$133.81 Million |
Quest PharmaTech Inc Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Quest PharmaTech Inc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CA$-511.88K | CA$-342.42K | CA$-554.68K | CA$-170.78K | CA$-2.52 Million |
| Capital Expenditures | CA$0.00 | CA$0.00 | CA$0.00 | CA$0.00 | CA$38.04K |
| Free Cash Flow | CA$-511.88K | CA$-342.42K | CA$-554.68K | CA$-170.78K | CA$-2.55 Million |
| Investing Cash Flow | — | — | CA$-14.00K | CA$-14.00K | CA$261.96K |
| Financing Cash Flow | CA$0.00 | CA$684.72K | CA$679.00K | CA$250.00K | CA$299.00K |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | CA$84.00K | CA$471.53K | CA$153.00K | CA$270.50K | CA$446.60K |
| Depreciation | CA$0.00 | CA$2.97K | CA$13.49K | CA$38.56K | CA$39.31K |
| Change in Cash | CA$-511.88K | CA$342.31K | CA$110.32K | CA$65.23K | CA$-1.95 Million |
Quest PharmaTech Inc Earnings History — EPS Actual vs. Analyst Estimates
Track Quest PharmaTech Inc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 28, 2026 | — | — | — |
| Dec 23, 2025 | — | — | — |
| Sep 29, 2025 | — | — | — |
| Jun 26, 2025 | — | — | — |
| Dec 11, 2024 | — | — | — |
| Jun 29, 2023 | -0.03 | — | — |
| Jan 31, 2023 | -0.03 | — | — |
| Oct 31, 2022 | -0.01 | — | — |